Abstract
Known causes of hepatocellular carcinoma (HCC) are chronic hepatitis B virus (HBV) infection; chronic hepatitis C virus (HCV) infection; dietary exposure to the fungal toxin, aflatoxin B1 (AFB1); cirrhosis, whatever its cause; the metobolic syndrome; hepatic iron overload and a number of rare inherited metabolic diseases. Of these, HBV and AFB1 are the predominant risk factors in those resource-poor countries in Eastern and South-Eastern Asia, the Western Pacific islands, and sub-Saharan Africa that have the highest incidences of the tumour. Closer analysis reveals that the association between exposure to AFB1 and the development of HCC has been reported almost exclusively in countries in which chronic HBV infection is endemic. This is a chance finding, although the possibility that AFB1 is hepatocarcinogenic only in the presence of HBV has been mooted. Chronic HBV infection is more common in rural areas of sub-Saharan Africa and exposure to AFB1 is virtually confined to these areas. Black patients in sub-Saharan Africa and Chinese patients in the Asian-Pacific region with HCC are appreciably younger than patients elsewhere in the world, which could be explained, at least in part, by synergism between the hepatocarcinogenic properties of the two risk factors. Such an interaction may also contribute to the very high incidence of HCC in these regions and to its higher frequency in rural than in urban dwellers in the African sub-continent.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahn JI, Jung EY, Kwun HJ, Lee CW, Sung YC, Jang KL (2002) Dual effects of hepatitis B virus X protein on the regulation of cell cycle depending on the ststus of cellular p53. J Gen Virol 83:2765–2772
Allen SJ, Wild CP, Wheeler JG, Riley EM, Montesano M, Bennett S Whittle HC, Hall AJ, Greenwood BM (1992) Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans Roy Soc Trop Med Hyg 86:426–430
Amaya-Farfan J (1999) Aflatoxin B1-induced hepatic steatosis: role of carbonyl compounds and active diols on steatogenesis. Lancet 353:747–748
Arteel GE (2003) Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124:778–790
Asare GA, Bronze M, Naidoo V, Kew MC (2007) Interaction between aflatoxin B1 and dietary iron overload in hepatic mutagenesis. Toxicology 234:157–166
Asare GA, Mossanda KS, Kew MC, Paterson AC, Kahler-Venter CP, Siziba K (2006) Hepatocellular carcinoma caused by iron overload: a possible mechanism of direct hepatocarcinogenicity. Toxicology 219:41–52
Asare GA, Bronze M, Naidoo V, Kew MC (2008) Synergistic interaction between excess hepatic iron and alcohol ingestion in hepatic mutagenesis. Toxicology 254:11–18
Austin A (1991) The role of tobacco use and alcohol consumption in the etiology of hepatocellular carcinoma. In: Tabor E, DiBiscegie AM, Purcell R, (eds) Etiology, pathology, and treatment of hepatocellular carcinoma in North America. Gulf Publishing Co, Houston, pp 57–76
Autrup H, Daneshvar LO, Dragsted M, Gamborgt M, Hansen S, Loft H (1999) Biomarkers of exposure to ambient air pollution — comparison of carcinogen-free DNA adduct levels and other exposure markers and markers for oxidative stress. Environ Health Perspect 107:233–238
Azziz-Baumgartner E, Lindblade L, Gieseker K, Schurz Rogers H, Kieszak S, Njapau H Schleicher R, McCoy LF, Misore A, DeCock K, Rubin C, Slutsker L (2005) Aflatoxin Investigative Group: case-control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environ Health Perspect 113:1779–1783
Bannasch P, Khoshkou NI, Hacker HJ, Raedeva S, Mrzek M, Zillmann U, Kopp-Schneider A, Haberkom U, Elgas M, Tolle T (1995) Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks. Cancer Res 55:3318–3330
Bartsch H, Nair J (2004) Oxidative stress and lipid peroxidation-derived DNA lesions in inflammatory-driven carcinogenesis. Cancer Detection Prev 28, 385–391.
Benhar M, Engelberg D, Levitzki A (2002) Reactive oxygen stress, stress-activated kinases and stress signalling in cancer, EMBO Rep 3:420–425
Bothwell TH, Bradlow BA (1960) Siderosis in the Bantu: a combined histopathological and chemical study. Arch Path 70:279–292
Bothwell TH, Isaacson C (1962) Siderosis in the Bantu: a comparison of incidence in males and females. Br Med J 1:522–524
Bothwell TH, Seftel H, Jacobs P, Torrance JD, Baumslag N (1964) Iron overload in Bantu subjects. Studies on the availability of iron in Bantu beer. Am J Clin Nutrit 14:47–51
Bressac B, Kew MC, Wands JR, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429–430
Brink B, Disler P, Lynch SR, Jacobs P, Charlton RW, Bothwell TH (1976) Patterns of iron storage in dietary iron overload and idiopathic haemochromatosis. J Lab Clin Med 88:725–731
Cadenzas E (1989) Biochemistry of oxygen toxicity. Ann Rev Biochem 58:79–110
Caro AA., Cederbaum A (2004) Oxidative stress, toxicology, and pharmacology of CYP2E1. Ann Rev Pharmacol Toxicol 44:9–18
Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S (1982) Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic haemochromatosis. Dig Dis Sci 27:909–916
Cheeseman KH (1993) Lipid peroxidation in cancer. In: Halliwell B, Arouma AI, (eds) DNA and Free Radicals. Ellis Horwood, London, pp 109–144
Chemin I, Ohgaki H, Chisari FV, Wild CP (1999) Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen. Liver 19:81–87
Chen C-J, Yu M-W, Liaw Y-F, Wang LW, Chiampresert S, Martin F, Hirvonen A, Bell DA, Santella RM (1996) Chronic hepatitis B carriers with null genotypes glutathione-S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Human Genet 59:128–134
Chen SY, Wang LY, Lun WY, Tsai PH, Lee CS, Ahsan YJ, Zhang VJ, Chen CJ, Santella RM (2002) Polycyclic aromatic hydrocarbon-DNA adducts in the liver tissues of hepatocellular carcinoma patients and controls. Internat J Cancer 99:14–21
Chen CJ, Zhang YJ, Lu SN, Santella RM (1992) Aflatoxin-B1-adducts in smeared liver tissue of hepatocellular carcinoma patients. Hepatology 16: 1150–1155.
Chen CH, Wang MH, Wang JH, Hung CH, Hu TH, Lee SC, Tung HD, Lee CM, Changchien CS, Chen PF, Hsu MC, Lu SN (2007) Aflatoxin exposure and hepatitis C virus in advanced liver disease in a hepatitis C virus endemic area in Taiwan. Am Trop Med Hyg 77:674–752
Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA (1992) 8-hydroxyl guanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 267: 166–172
Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Prinkert CA, Brinster RL, Palmiter RD (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B transgenic mice. Cell 59:1145–1156
Chung FL, Nath RG, Ocando J, Nishkawa A, Zhang L (2000) Deoxyguanine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res 60:1507–1511
Cova L, Wild CP, Mehrotra R, Tursov V, Shirai T, Lambert V, Jaquet C, Tomatis L, Trepo C, Montesano R (1990) Contribution of aflatoxin B1 and duck hepatitis B virus in the induction of liver tumors in ducks. Cancer Res 50:2156–2163
Dabbagh AJ, Mannion T, Lynch SM, Frei B (1994) The effect of iron overload on rat plasma and liver oxidant status in vivo. Biochem J 300:799–803
De Flora S, Hietane E, Bartsch H, Camoirano A, Izzotti A, Bagnasco M, Millman I (1989) Enhanced metabolic activation of chemical hepatocarcinogenesis in woodchucks infected with woodchuck hepatitis virus. Carcinogenesis 10:1099–1106
Del Olmo JA, Serra MA, Rodriguex F, Escudero A, Gilabert S, Rodrigo JM (1998) Incidence and risk fractors for hepatocellular carcinoma in 967 patients with cirrhosis. J Cancer Res Clin Oncol 124:560–564
Deugnier Y (2003) Iron and liver cancer. Alcohol 30:145–150
Deugnier YM, Guyader D, Crantock L, Lopez JM, Turlin B, Yaouang J, Jouanolle H, Campion JP, Launois B, Halliday JW (1993) Primary liver cancer in genetic haemochromatosis: a clinical, pathological and pathogenetic study of 54 cases. Gastroenterology 104:228–234
Eaton DL, Gallagher EP (1994) Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 34:135–172
Esterbauer H (1993) Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 57(suppl):779–860
Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 11:81–128
Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:S35–S50
Feng Z, Hu W, Tang MS (2004) Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: A possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci USA 101:8598–9602
Fletcher LM, Powell LW (2003) Hemochromatosis and alcoholic liver disease. Alcohol 30: 131–136
Gangaidzo IT, Gordeuk VR (1995) Hepatocellular carcinoma and African iron overload. Gut 37:727–730
Gemechu-Hatewu M, Platt K-L, Oesch F, Hacker HJ, Bannasch P, Steinberg P (1997) Metabolic activation of aflatoxin B1 to aflatoxin B1–8,9-epoxide in woodchucks undergoing chronic active hepatitis. Int J Cancer 73:587–591
Gordeuk VR, Boyd RD, Brittenham GM 1986 Dietary iron overload persists in rural sub-Saharan Africa. Lancet 1:1310–1313
Green R, Esparza I, Schreiber R 1988 Iron inhibits the non-specific tumoricidal activity of macrophages. A possible contributory mechanism for neoplasia in hemochromatosis. Ann N Y Acad Sci 526:301–309
Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan JN, Montesano R (1992) Molecular dosimetry of aflatoxin-N7 - guanine in human urine obtained in The Gambia. Cancer Epidemiol Biomarkers Prev 1:221–227
Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BM, Chisari FV (1994) Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acd Sci USA 91:12808–12812
Hon WM, Lee KH, Khoo HE (2002) Nitric oxide in liver diseases: friend, foe, or just passer-by? Ann NY Acad Sci 962:275–295
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond) 350:427–428
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (1994) Hepatitis B Virus. IARC, Lyon 59:45–164
Hu W, Tang MS (2004) Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: A possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci USA 101:8598–9602
Hussain SP, Aquilar F, Amstad P, Cerutti P (1994) Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene 9:2277–2281
Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel TJ, Wogan GN, Hofseth LJ, Shields PG, Billiar TR, Trautwein C, Hohler T, Galle PR, Phillips DH, Markin R, Morraji AJ, Harris CC (2000) Increased p53 mutation load in non-tumorous human liver of Wilson disease and haemochromatosis: Oxyradical overload disease. Proc Natl Acad Sci U S A 97:12770–12775
Ichiba M, Maeta Y, Mukoyama T, Saeki T, Yasui S, Kanbe T, Okano J, Tanabe Y, Hirooka Y, Yamada S, Kurimasa A, Murawaki Y, Shiota G (2003) Expression of 8-hydroxy-2′-deoxyguanosine in chronic liver disease and hepatocellular carcinoma. Liver Internat 23:1781–1789
Ioannou GN (2000) The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 126:1293–1301
Isaacson C, Seftel HC, Keeley KJ, Bothwell TH (1961) Siderosis in the Bantu: the relationship between iron overload and cirrhosis. J Lab Clin Med 58:845–853
Ishima H, Bartsch H (1994) Chronic infection and inflammatory processes as cancer risk factors: possible role for nitric oxide in carcinogenesis. Mutation Res 305:253–264
Jacobovits A, Morgan MY, Sherlock S (1979) Hepatic siderosis in alcoholics. Dig Dis Sci 24:305–310
Jia L, Wang XW, Harris CC (1999) Hepatitis B virus x protein inhibits nucleotide excision repair. Int J Cancer 80:875–879
Jungst C, Cheng B, Gehrke R, Schmitz V, Nischalke HD, Ramakers J, Schramel P, Schirmacher P, Sauerbruch C, Caselmaan WH (2004) Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology 39:1663–1672
Kew MC (1992) Chronic hepatitis-B virus infection and hepatocellular carcinoma in Africa. S Afr J Sci 88:524–528
Kew MC, Asare GA (2007) Dietary iron overload in the African and hepatocellular carcinoma. Liv Internat 27:735–741
Kew MC, Popper H (1984) Relationship between hepatocellular carcinoma and cirrhosis. Semin Liv Dis 4:136–146
Kim YM, Chung HT, Simmons RL, Billia TR (2000) Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 275:10954–10961
Kimbi GA, Kew MC, Yu MC, Arakawa K, Hodkinson J (2005) 249 serine p53 mutation in the serum of black southern Africans with hepatocellular carcinoma. J Gastro Hepatol 20:1185–1190
Kirby G, Chemin I, Montesano R, Chisari FV, Lang MA, Wild CP (1994) Induction of specific cyotochrome p-450s involved in aflatoxin B1 metabolism in hepatitis B transgenic mice. Mol Carcinogenesis 11:74–80
Kirk GD, Lesia OA, Mendy M, Szymanska K, Whittle H, Goedert JT, Hainaut P, Montesano R (2005) 249 ser TP53 mutation in plasma, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene 24:5858–5867
Kruszewsky M (2003) Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res 531:81–92
Kuang SY, Lekawanvijit S, Maneenkarn N, Thongswat S, Brodovicz K, Nelson K, Groopman JD (2005) Hepatitis B 1762T/1764A mutations, hepatitis C infection and codon 249 p53 mutations in hepatocellular carcinomas in Thailand. Cancer Epidemiol Biomarkers Prev 14: 380–384
Kuniholm MH, Lesis OA, Mendy M, Akano AO, Sam O, Hall AJ, Whittle H, Bah E, Goedert JJ, Hainaut P, Kirk GD (2008) Aflatoxin exposure and viral hepatitis in the etiology of cirrhosis in The Gambia, West Africa. Environ Health Perspect 116:1553–1557
Kuper H, Ye W, Broome U, Romelsjo A, Mucci LA, Ekbom A, Adami HO (2001) The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, and cirrhosis. Hepatology 34:714–718
Lieber CS, DeCarli LM (1970) Hepatic microsomal ethanol-oxidizing systems: in vitro characteristics and adaptive properties. J Biol Chem 245:2505–2512
Liu RH, Jacob JR, Hotchkiss JH, Cote PJ, Gerin JL, Tennant BC (1994) Woodchuck hepatitis virus surface antigen induces nitric oxide synthesis in hepatocytes: possible role in hepatocarcinogenesis. Carcinogenesis 15:2875–2877
Loeb LA, James EA, Waltersdorph AM, Klebanorf SJ (1988) Mutagenesis by the autoxidation of iron with isolated DNA. Proc Natl Acad Sci U S A 85:3918–32
Lunn RM, Zhang Y-J, Wang L-Y, Chen CJ, Lee PH, Lee CS, Tsai WY,Santella RM (1997) Mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 57:3471–3477
McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T, Wild CP, Xia XL, Baffoe-Bonnei A, Ofori-Adjei D (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 92:2384–2387
MacPhail AP, Mandishona E, Bloom P, Paterson AC, Rouault TA, Gordeuk VR (1999) Measurements of iron status and survival in African iron overload. S Afr Med J 89:966–972
Marrogi AJ, Khan MA, van Gijssel HE, Welsh JA, Rahim H, Demetris AJ, Kowdley V, Hussain SP, Nair J, Bartsch H, Okby N, Poirier MC, Ishak KG, Harris CC (2001) Oxidative stress and p53 mutations in the carcinogenesis of iron-overload-associated hepatocellular carcinoma. J Natl Cancer Inst 93:1652–1655
Matzner Y, Hershko C, Polliak K, Konijn A, Izak G (1979) Suppressive effect of ferritin on in vitro lymphocyte function. Br J Hematol 42:443–448
McKillop IH, Schrum LW (2005) Alcohol and liver cancer. Alcohol 35:195–203
Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, Wang L, Shao Y, Wu Z, Wang X, Sun Z (2002) Dominant role of hepatitis B virus and co-factor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 36:1214–1220
Moyo VM, Gangaidzo IT, Gomo ZA, Khumalo H, Saungweme T, Kiire CF, Roualt T, Gordeuk VR (1997) Traditional beer consumption and the iron status of spouse pairs from a rural community in Zimbabwe. Blood 89:2159–2166
Murata H, Tsuji S, Tsuji, M, Sakaguchi Y, Fu HY, Kawano S, Hori M (2004) Promoter hypermethylation silences cyclo-oxygenase-2 (cox-2) and regulates growth of human hepatocellular carcinoma cells. Lab Invest 84:1050–1059
Niederau C, Fisher R, Sonnenberg A, Stremmel W, Trampisch HAJ, Stromeyer MD (1985) Survival and causes of death in cirrhotic and non-cirrhotic patients with primary haemochromatosis. N Engl J Med 313:11256 1262
Obe G, Ristow H (1979) Mutagenic, cancerogenic and teratogenic effects of alcohol. Mutat Res 65:229–259
Orimo H, Toura Y, Hino R, Kasai H (2006) Formation of 8-hydroxy-2′-deoxyguanosine in the DNA of cultured keratinocytes by clinically used doses of narrowband and broadband B and psoralen plus ultraviolet light. Cancer Sci 97:99–105
Ozturk M (1991) A p53 mutational hotspot in primary liver cancer is geographically localised to high aflatoxin areas of the world. Lancet 338:260–265
Peers F, Bosch X, Kaldor J, Linsell A, Pleijmen M (1987) Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer 39:545–553
Petersen DR (2005) Alcohol, iron-associated oxidative stress, and cancer. Alcohol 35:2 43–249
Poschl G, Seitz HK (2004) Alcohol and cancer. Alcohol 39:155 –165
Probst C, Njapau H, Cotty PJ (2004) Outbreak of acute aflatoxicosis in Kenya in 2004: identification of the causal agent. Appl Environ Microbiol 73:2762–2764
Qian GS, Ross RK, Yu MC, Yan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3:3–10
Ratziu V, Poynard T (2005) Hepatocellular carcinoma in NAFLD. In: Farrell GC, George J, de la Hall P, McCullough AJ, (eds) Fatty liver disease: NASH and related disorders. Blackwell, Oxford, 276–288
Rouault TA (2003) Hepatic iron overload in alcoholic liver disease: why does it occur and what is its role in pathogenesis? Alcohol 30:103 – 106
Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE (1992) Urinary aflatoxin biomarkers and the risk of hepatocellular carcinoma. Lancet 339: 943–946
Sakamoto T, Hara M, Higaki Y, Ichiba M, Horita M, Mizuta T, Eguchi Y, Yasatake T, Osaki I, Yamamoto K, Onohara S, Kawasoe S, Shigematsu H, Tanaka K (2006) Influence of alcohol consumption and gene polymorphisms of ADH2 and ALDH2 on hepatocellular carcinoma in a Japanese population. Int J Cancer 118:1501–1507
Sell S, Hunt JM, Dunsford HA, Chisari FV (1991) Synergy between hepatitis B virus expression and chemical hepatocarcinogenesis in transgenic mice. Cancer Res 51:1278–1285
Sheu J-C, Huang G-T, Lee P-H, Chung JC, Chou HC, Lai My, Wang JT, Lee HS, Shih LN, Yang PM (1992) Mutations of p53 in hepatocellular carcinomas in Taiwan. Cancer Res 52: 6098–6100
Stern MC, Umbach DM, Yu MC, London SJ, Zhang Z-Q, Taylor JA (2001) Hepatitis B, aflatoxin B1, and p53 codon 249 mutation in hepatocellular carcinoma from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Cancer Epidemiol Biomark Prev 10:617–625
Stickel F, Schuppan D, Hahn EG, Seitz HK (2002) Carcinogenic effects of alcohol in hepatocrcinogenesis. Gut 1:132–139
Sun C-A, Wang L-Y, Chen C-J, Lu SN, You SL, Wang LW, Wang O, Wu DM, Santella RM (2001) Genetic polymorphisms of glutathione-S-transferases M1 and T1 associated with susceptibility to aflatoxin-related carcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis 22:1289–1294
Sun CA, Wu DM, Wang LY, Chen CJ, You SL, Santella RM (2002) Determinants of formation of aflatoxin-albumin adducts: a seven township study in Taiwan. Br J Cancer 87:966–970
Sun Z, Lu P, Gail MH, Pee D, Zhang O, Ming L, Wang J, Wu Y, Liu G, Wu Y, Zhu Y (1999) Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 30: 379–383
Tavill AS, Qadri AM (2004) Alcohol and iron. Semin Liver Dis 24:318–325
Tennant BC, Hornbuckle WE, Yeager AE, Cote PJ, Baldwin BH, Korba BE (1990) Effects of aflatoxin B1 on experimental woodchuck hepatitis virus infection and hepatocellular carcinomas. In: ` Hollinger FB, Lemon SM, Margolis H (eds) Viral Hepatitis and Liver Disease. Williams and Wilkins, Baltimore, pp 599–600
Troadec M-B, Courselaud B, Detwaud L, Haziza-Pigeon C, Leroyer P, Brissot P, Loreal O (2006) Iron overload promotes cyclin D1 expression and alters cell cycle in mouse hepatocytes. J Hepatol 44:391–399
TsuTsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, Yla-Herttuala S, Brittenham GM (1995) Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620–630
Turner PC, Mendy M, Whittle H, Fortuin M, Hall AJ, Wild CP (2000) Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop Med Int Health 5:837–841
Vadrot N, Legrand A, Nello E, Bringuier AF, Guillot R, Feldman G (2006) Inducible nitric oxide synthase could be responsible for resistance or sensitivity to IFN-gamma-induced apoptosis in several human hepatoma cell lines. J Interferon Cytokine Res 26:901–913
Valberg LS, Simon JB, Manley PM, Corbett WE, Ludwig J (1975) Distribution of storage iron as body stores expand in patients with haemochromatosis. J Lab Clin Med 86:479–489
Vautier G, Bomford AB, Portmann BC, Metivier E, Williams R (1999) p53 mutations in British patients with hepatocellular carcinoma: clustering in genetic hemochromatosis. Gastroenterology 117:154–160
Wacker M, Wanek P, Eder E (2001) Detection of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats. Chem Biol Interact 137:269–83
Walker ARP, Arvidsson UB (1953) Iron overload in the South African Bantu. Tr Roy Soc Trop Med Hyg 47:536–548
Wang L-Y, Hatch M, Chen C-J, Levin B, You SL, Lu SN, Wu MH, Wu MP, Wang LW, Wang Q, Huang GT, Yang PM, lee HS, Santella RM (1996a) Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Br J Cancer 67:620–630
Wang JS, Qian GS, Zarba A, He X, Zhu YR, Zhang BC, Jacobson L, Gange SL, Munoz A, Kensler TW (1996b) Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and -negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol Biomarkers Prev 5:253–261
Wild CP, Fortuin M, Donato F, Whittle HC, Hall AJ, Wolf CR, Montesana R (1993) Aflatoxin, liver enzymes and hepatitis B virus infection in Gambian children. Cancer Epidemiol Biomarkers Prev 2:555–561
Wild CP, Rasheed FN, Jawla MF, Hall AJ, Jansen LA, Montesano R (1991) In-utero exposure to aflatoxin in West Africa. Lancet 337:1602
Wu HC, Wang Q, Wang LW, Yang HI, Ahsan H, Tsai WY, Tsai MW, Wanh LY, Chen SY, Chen SJ, Santella R (2007) Polycyclic aromatic hydrocarbons and aflatoxin;albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Cancer Lett 252:104–114
Yeh F-S, Yu MC, Mo C-C, Luo S, Tong MJ, Henderson BE (1989) Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi. China Cancer Res 49:2506–2509
Yu M-W, Lien J-P, Chiu Y-H, Santella RM, Liaw Y-F, Chen C-J (1997) Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol 27:120–130
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kew, M.C. (2009). Interaction Between Aflatoxin B1 and Other Risk Factors in Hepatocarcinogenesis. In: Rai, M., Varma, A. (eds) Mycotoxins in Food, Feed and Bioweapons. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00725-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-00725-5_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00724-8
Online ISBN: 978-3-642-00725-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)